Black Cohosh Presentation Created by: Shannon Liu, Anthony Der.

Slides:



Advertisements
Similar presentations
© 2013 North American Menopause Society. Menopause. 2013;20(9): Key points from the 2013 Position Statement of The North American Menopause Society.
Advertisements

Valerian:Efficacy in Stress/Anxiety Reduction and as a Sleep Aide.
Breast cancer chemoprevention in the high-risk patient
Rare Film Guide Slide Set. Clinical Trial Design for Pirfenidone Study Purpose of Study: To see if the use of pirfenidone decreases the loss of lung function.
Research Study Designs
Clinical Trials Importance in future therapies. What are the Requirements to Produce New Drugs? Drug must work significantly better than a control treatment.
Robertson JFR et al. J Clin Oncol 2009;27(27):
Clinical Trials Medical Interventions
Ibrance® - Palbociclib
Miracle Herb 2000: A Look at the Evidence Ann Zweber and Roberto Linares Oregon State University College of Pharmacy Introduction Miracle Herb 2000 has.
The Affect Common Chemicals May Have on Women’s Hormone Therapy Presented By: Sean Snowden.
Herceptin® (trastuzumab) in combination with chemotherapy: pivotal metastatic breast cancer survival data 1.
Harvoni® ledipasvir/sofosbuvir
Hormone Replacement Therapy
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Dietary Supplements.  Intended to supplement the diet  Contains one or more ingredients  Intended to be taken by mouth (but is not a food)  Labeled.
Soy & Breast Cancer Michelle Sulprizio Student Dietitian Community Servings Spring 2013.
PhytElleTM A superior formulation to support women’s health. The special combination of plant extracts and herbs offers relief from symptoms associated.
To treat or not to treat? Highly individualized. Debilitating symptoms. Mild symptoms.
This examination stems from the desire explore the controversial topic of pharmacological therapy versus nonpharmacological therapy in treatment of vasomotor.
Medcan Women’s Health Forum It’s The Menopause! Wilfred M Steinberg MD FRCSC University of Toronto St Michael’s Hospital.
Drug development  Recognise the use of plants as sources of medicines.  Describe the drug development process.  Compare historic drug testing with contemporary.
Afrezza® – inhaled human insulin
Basic Reproduction From
The lowdown on Ginkgo Biloba Gold, PE at al.. Use of Ginkgo Biloba can be traced back centuries in Chinese traditional medicine Most widely-used herbal.
Integrative Medicine and Phytotherapy Chapter 20.
Taxane-pretreated metastatic breast cancer (MBC): investigational agents TTP = median time to disease progression OS = median overall survival.
1 Kepivance™ (Palifermin) Basis for Approval and Pediatric Studies Kepivance™ (Amgen) Approved 12/15/04 Joseph E. Gootenberg, M.D. Office of Oncology Drug.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
A randomized crossover trial of venlafaxine (V) versus gabapentin (G) for hot flashes in breast cancer survivors Louise J Bordeleau 1, Olivera Jugovic.
The Effects of Inositol on Women with Polycystic Ovary Syndrome(PCOS)
A randomized, double-blinded, placebo-controlled study of the effect of a combination of lemon verbena extract and fish oil omega-3 fatty acid on joint.
1Bachelot T et al. Proc SABCS 2010;Abstract S1-6.
A Study on the Efficacy of Non- Hormonal Therapies in Treating Menopausal Symptoms Gerri Cassedy RT (R) April, 18, 2008 East Tennessee State University.
Food and Drug Administration Regulatory Implications of The WHI Study Eric Colman, MD Center for Drug Evaluation and Research Division of Metabolic and.
Sprout Pharmaceuticals Inc. FDA Approval Date: August 18, 2015
APRIL AYERS JEFF GIBBERMAN MELISSA HSU EL-KAMARYA SS, SHARDELLA MD, ABDEL-HAMID M, ET AL. A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY.
Non-hormonal therapy Marco Gambacciani and Paula Albertazzi.
A health magazine recently reported a study in which researchers claimed that iron supplements increased memory and problem-solving abilities in a random.
Please feel free to chat amongst yourselves until we begin at the top of the hour.
Menopause. * 1/3 people self administer natural remedies * More women than men * 70% fail to report use to their MDs * Not necessarily safer than prescription.
SNDA Letrozole (Femara®) Indication: First-line therapy in post- menopausal women with advanced breast cancer. Prior approval: Second-line therapy.
What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.
Manufacturer: Amgen Inc FDA Approval Date: August 27, 2015
A Pharmacokinetic Drug Interaction Study of Drug-72 and Drug-12 Department of Mathematic & Statistics York University Yufeng Lin Xiaofeng Zhou.
S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.
Responses to Subsequent Anti-HER2 Therapy After Treatment with Trastuzumab-DM1 in Women with HER2- Positive Metastatic Breast Cancer 1 A Phase Ib/II Trial.
Manufacturer: AstraZeneca FDA Approval Date: December 22, 2015
Journal Club 9/15/11 Sanaz Sakiani, MD 1 st Year Endocrine Fellow Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics.
Osphena® (ospemifene) Stefanie L Drahuschak University of Pittsburgh PharmD Candidate 2014.
升麻檔案 中文名 升麻 學名 Cimicifuga foetida / Cimicifugae Rhizoma 英文名 Rhizome of Largetrifolious Bugbane 拉丁名 Rhizoma Cimicifuge 別名 黑升麻、綠升麻、西升麻、雞骨升麻、周升麻、鬼臉 升麻.
Casodex 50mg - Prostate Cancer Drug Casodex 50 mg is a prostate cancer drug used in hormonal therapy to treat the same. It reduces production of androgen.
SC300 Unit Five Phyllis J. Langone, Ph.D., M.Phil., M.B.A., M.S., M.A. AIM:
GASTROENTEROLOGY 2008; 134 :688–695 소화기내과 R4 이 재 연.
J Clin Oncol 30: R2 윤경한 / Prof. 김시영 Huan Jin, Dongsheng Tu, Naiqing Zhao, Lois E. Shepherd, and Paul E. Goss.
By Christine Batten and Ryan Thibodaux. Wolfporia extensa A wood decay fungus Found worldwide Also known as: Hoelen Poria Tuckahoe China Root Indian Bread.
Herbal way to relieve menopausal symptoms Natural remedies for menopause We often hear women talking about middle-aged menopausal and menopausal symptoms.
Menotropins Drugbank ID : DB00032
Nuplazid™ - Pimavanserin
Eucrisa™ - Crisaborole
Copyright © 2016 by Mosby, an imprint of Elsevier Inc.
Drug Discovery &Development
Clinical Trials Medical Interventions
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Clinical Trials.
Bergh J et al. SABCS 2009;Abstract 23.
ONCOLOGYEDUCATION.COM ARTICLE SUMMARIES
Major classes of drugs to reduce lipids
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Black Cohosh Presentation Created by: Shannon Liu, Anthony Der

Black Cohosh: About the Plant Cimicifuga racemosa Roots and rhizomes are the basis for the extraction (not the flowers) ◦ Can be extracted using alcohols Extracts contain 26-deoxyactein ◦ Member of the triterpene glycosides ◦ In most extractions, approximately 1 mg of triperpene per 20 mg dose of extract Generally grown in temperate to cold weather in damp, fertile soil (forests). [12]

Traditional Uses Most common treatments using black cohosh: hormonal imbalances ◦ Primarily menopause and breast cancer  Effectiveness has been tested in controlled studies  Popular in Germany for climacteric symptoms (time before menopause)  One of the very first trials testing the effectiveness of black cohosh was run in 1989 by the German Commission E ◦ Traditional uses dating back to Native Americans for other remedies for:  Sore throat  inducing lactation  Diuretics  Fever  Gynecological disorders  “Conditions that affected women’s reproductive organs” [13], [14]

Marketed Uses and Disclaimers Some books/sites recommend growing and extracting your own black cohosh roots by collecting black cohosh, drying the roots, and then creating tinctures out of them Possible side effects ◦ Nausea ◦ Vomiting ◦ upset stomach ◦ A few reports of liver disease Overdose of black cohosh ◦ Dizziness ◦ Slowed heart rate ◦ Tremors ◦ Light-headedness No long term data (more than 6 months) ◦ Therefore generally not recommended to take for more than 6 months Shown to have possible interactions with hormonal replacement drugs [15]

Female Reproductive System Key concepts ◦ Anatomy – ovary, endometrium ◦ Ovariectomy ◦ Estrogen and estrogen receptors (ER) Menopause ◦ Lowered hormone levels [10]

Pharmacodynamics Mechanism of action: unknown, but possible estrogenic effect ◦ 4 studies indicate some estrogenic effect ◦ 3 studies indicate no relationship [1] – [9]

Pharmacodynamics Evidence for Estrogen Receptor (ER) mechanism Kruse et al: Fukinloic acid caused increased proliferation of an estrogen dependent MCF-7 cell system  Fukinolic acid has estrogenic activity Düker et al: Remifemin suppresses LH levels, due to at least 3 synergistically acting compounds Dixon: consumption of phytoestrogen-rich foods causes inhibition of MCF-7 and T-47 breast cancer cell growth Liu, Yang et al: increasing dosage of black cohosh allowed for uterine weight increase, prolonged estrus  Black cohosh has a stimulating effect on estrogen receptors. [1], [2], [4], [5]

Pharmacodynamics Refuting evidence for Estrogen Receptor mechanism Liu, Burdette et al: No indication of estrogenic activity in estrogen receptors of endometrial cells Einer et al: no relationship between black cohosh and uterine weight Freudenstein et al: administered black cohosh or estrogen after inducing tumors and performing ovariectomy in rats; no significant difference in cancer growth or estrogen sensitive organs [3], [6], [7]

Pharmacokinetics Minimal research on pharmacokinetics of black cohosh ◦ Some evidence that it weakly inhibits CYP2D6 (Gurley et al) Clinical study underway: Pharmacokinetics of Black Cohosh ◦ Duke University Medical Center, NCCAM ◦ Investigation of levels of components of black cohosh obtained in the blood of healthy women taking Remifemin. [8]

Black Cohosh and Breast Cancer (First Study) Approximately 2/3 of breast cancer survivors undergo hot flashes ◦ A double blind study was done to see if black cohosh would minimize the hot flashes received by the women ◦ Women were selected based off of a demographic survey and also had other criteria met (completed primary therapy at least two months before trial) ◦ Instructed to take tablets twice daily with meals for 60 days.  The women were supposed to count the number of hot flashes for a three day period before the trial as well as severity (on a 1-3 scale, of mild, moderate, or severe)  At the day mark and the day mark the women went through the same process [15]

Black Cohosh and Breast Cancer (First Study) Total of 85 study participants ◦ Both the placebo and no placebo group reported lowered number of hot flashes  Although 59 of the patients were using tamoxifen, this had no foreseeable effect on the study  However, the overall difference between the placebo group and the group taking the black cohosh extract pill was not significant  (P =.86 via analysis of covariance adjusting for baseline number and for tamoxifen use) ◦ Limitation of the study  Trial period was only for 2 months, due to concern of patients dropping out of the study due to lack of benefits  16 people out of the 85 dropped out of the study [15]

Black Cohosh and Breast Cancer (Second Study) Another, similar study was done also involving 132 women with breast cancer and hot flashes ◦ A double blind study, with the trial being 2 4-weeks long ◦ In this study, a daily hot flash record was kept instead of three specific dates ◦ Once again, the amount of hot flashes experienced by women decreased in both the placebo groups and the Black Cohosh group, yet the difference between the two was not significant enough to show that Black Cohosh was the cause of the decrease. ◦ Placebo effect [16], [17]

Black Cohosh and Menopause A study of 351 women peri or postmenopausal women between the ages of 45 and 55, were randomly assigned a 150 or 200 mg of a Black cohosh, a dietary supplement, a hormonal therapy pill, or a placebo ◦ The black cohosh was provided by Pure World Inc. ◦ This study lasted for a year ◦ Once again, the study indicated that the black cohosh groups had no significant difference with the women that were in the placebo group  Any decreases in hot flashes were mostly contributed to either the placebo effect, or that hot flashes naturally decline over time [18]

Black Cohosh: It Works? One study claimed that black cohosh was effective in treating climacteric symptoms in women. ◦ Double blind study, with 304 women for twelve weeks 2.5 mg isopropanolic extract of Cimicifuga Racemosa in the black cohosh pill. ◦ Results showed a significant change of the patients using the black cohosh pill So What Went Wrong? ◦ The data reporting is skewed, the scale used in the data does not accurately measure the amount of hot flashes per day, but actually measures the relationship between ability to sleep and type of pill taken without taking into account the number of hot flashes each women had. [19]

Contraindictions Until the relationship between black cohosh and hormones has been better established, women should avoid taking black cohosh… ◦ During pregnancy ◦ For the treatment of breast cancer ◦ In combination with other hormonal treatments Herb-drug interactions of black cohosh have not yet been sufficiently studied [11]

Black Cohosh in summary… Alternative medicine sometimes used to alleviate menopausal symptoms, some evidence of anti- cancer Few studies supporting effectiveness of black cohosh for the above but also many refuting the effectiveness ◦ Most studies have their own limitations, which hinder the effectiveness of the study  Number of people in the study  Duration of study  Limited info on extraction and dosage Further research can be done to solidify existing evidence

References 1. Kruse SO, Lohning A, Pauli GF, Winterhoff H, Nahrstedt A: Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Medica 65: , Düker EM, Kopanski L, Jarry H, Wuttke W: Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica 57: , Liu J, Burdette JE, Xu H, et al.: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. Journal of Agricultural and Food Chemistry. 49: , Dixon-Shanies D, Shaikh N: Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncology Reports 6: , Liu Z, Yang Z, Zhu M, Huo J: Estrogenicity of black cohosh (Cimicifuga racemosa) and its effect on estrogen receptor level in human breast cancer MCF-7 cells (in Chinese). Wei Sheng Yan Jiu 30: 77-80, Einer-Jensen N, Zhao J, Anderson KP, Kristoffersen K: Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25: , Freudenstein J, Dasenbrock C, Nisslein T: Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Research 62: , Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry DB, Khan IA, Shah A. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes. Clinical Pharmacology & Therapeutics 77: , National Center for Complementary and Alternative Medicine, NIH Office of Dietary Supplements. Workshop on the Safety of Black Cohosh in Clinical Studies. November 22, Silverthorn, D (2007). Human Physiology. San Francisco, CA: Pearson.

References 11. Office of Dietary Supplements and National Center for Complementary and Alternative Medicine. Questions and Answers About Black Cohosh and the Symptoms of Menopause 12. Duke JA: Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 2001: Foster S: Black cohosh: Cimicifuga racemosa: a literature review. HerbalGram 45: 35-49, Upton, R, ed. Black Cohosh Rhizome Actaea racemosa L. syn. Cimicifuga racemosa (L.) Nutt. Standards of analysis, quality control, and therapeutics. American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA. American Herbal Pharmacopoeia, 2002: Judith S. Jacobson, Andrea B. Troxel, Joel Evans, Lorissa Klaus, Linda Vahdat, David Kinne, K. M. Steve Lo, Anne Moore, Pamela J. Rosenman, Elizabeth L. Kaufman, Alfred I. Neugut, and Victor R. Grann Randomized Trial of Black Cohosh for the Treatment of Hot Flashes Among Women With a History of Breast Cancer J Clin Oncol May 15;19(10): Sloan JA, Loprinzi CL, Novotny PJ, et al: Methodologic lessons learned from hot flash studies. J Clin Oncol 19: , Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol Jun 20;24(18): Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan, J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med Dec 19;145(12): Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol Sep;106(3):644